NF-κB Binds P-TEFb to Stimulate Transcriptional Elongation by RNA Polymerase II

[1]  E. Cho,et al.  Different phosphorylated forms of RNA polymerase II and associated mRNA processing factors during transcription. , 2000, Genes & development.

[2]  E. Sausville,et al.  Flavopiridol Inhibits P-TEFb and Blocks HIV-1 Replication* , 2000, The Journal of Biological Chemistry.

[3]  K. Yamamoto,et al.  The glucocorticoid receptor inhibits NFkappaB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain. , 2000, Genes & development.

[4]  M. Garber,et al.  CDK9 Autophosphorylation Regulates High-Affinity Binding of the Human Immunodeficiency Virus Type 1 Tat–P-TEFb Complex to TAR RNA , 2000, Molecular and Cellular Biology.

[5]  J. Harton,et al.  Class II Transactivator: Mastering the Art of Major Histocompatibility Complex Expression , 2000, Molecular and Cellular Biology.

[6]  Junmin Peng,et al.  Tat Modifies the Activity of CDK9 To Phosphorylate Serine 5 of the RNA Polymerase II Carboxyl-Terminal Domain during Human Immunodeficiency Virus Type 1 Transcription , 2000, Molecular and Cellular Biology.

[7]  D. Price.  P-TEFb, a Cyclin-Dependent Kinase Controlling Elongation by RNA Polymerase II , 2000, Molecular and Cellular Biology.

[8]  J. Lis,et al.  P-TEFb kinase recruitment and function at heat shock loci. , 2000, Genes & development.

[9]  V. Orlando,et al.  Mapping chromosomal proteins in vivo by formaldehyde-crosslinked-chromatin immunoprecipitation. , 2000, Trends in biochemical sciences.

[10]  R. Roeder,et al.  TIP30 has an intrinsic kinase activity required for up‐regulation of a subset of apoptotic genes , 2000, The EMBO journal.

[11]  B. Peterlin,et al.  Tat transactivation: a model for the regulation of eukaryotic transcriptional elongation. , 1999, Virology.

[12]  T. Gilmore,et al.  Control of apoptosis by Rel/NF-κB transcription factors , 1999, Oncogene.

[13]  D. Eick,et al.  Transcriptional Regulation of the Igκ Gene by Promoter-Proximal Pausing of RNA Polymerase II , 1999, The Journal of Immunology.

[14]  J. Lis,et al.  Transcription Factor TFIIH Is Required for Promoter Melting In Vivo , 1999, Molecular and Cellular Biology.

[15]  B. Cullen,et al.  Recruitment of cyclin T1/P-TEFb to an HIV type 1 long terminal repeat promoter proximal RNA target is both necessary and sufficient for full activation of transcription. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[16]  J. Karn,et al.  Stimulation of Tat‐associated kinase‐independent transcriptional elongation from the human immunodeficiency virus type‐1 long terminal repeat by a cellular enhancer , 1999, The EMBO journal.

[17]  B. Peterlin,et al.  Interactions between human cyclin T, Tat, and the transactivation response element (TAR) are disrupted by a cysteine to tyrosine substitution found in mouse cyclin T. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[18]  B. Peterlin,et al.  The Ability of Positive Transcription Elongation Factor b To Transactivate Human Immunodeficiency Virus Transcription Depends on a Functional Kinase Domain, Cyclin T1, and Tat , 1998, Journal of Virology.

[19]  R. G. Keene,et al.  Transcriptional pausing at +62 of the HIV-1 nascent RNA modulates formation of the TAR RNA structure. , 1998, Molecular cell.

[20]  G. Evan,et al.  Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB , 1997, Nature.

[21]  D. Price,et al.  Control of RNA Polymerase II Elongation Potential by a Novel Carboxyl-terminal Domain Kinase* , 1996, The Journal of Biological Chemistry.

[22]  B. Cullen,et al.  Functional similarities between HIV-1 Tat and DNA sequence-specific transcriptional activators. , 1995, Virology.

[23]  M. Groudine,et al.  Cellular latency in human immunodeficiency virus-infected individuals with high CD4 levels can be detected by the presence of promoter-proximal transcripts. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[24]  D. Reinberg,et al.  Dual role of TFIIH in DNA excision repair and in transcription by RNA polymerase II , 1994, Nature.

[25]  R. Tjian,et al.  Transcription factor IIE binds preferentially to RNA polymerase IIa and recruits TFIIH: a model for promoter clearance. , 1994, Genes & development.

[26]  B. Peterlin,et al.  Synergism between Tat and VP16 in trans-activation of HIV-1 LTR. , 1993, Journal of molecular biology.

[27]  B. Cullen,et al.  Genetic analysis of the cofactor requirement for human immunodeficiency virus type 1 Tat function , 1993, Journal of virology.

[28]  M. Malim,et al.  The VP16 transcription activation domain is functional when targeted to a promoter-proximal RNA sequence. , 1992, Genes & development.

[29]  R. Gaynor,et al.  TAR independent activation of the human immunodeficiency virus in phorbol ester stimulated T lymphocytes. , 1990, The EMBO journal.

[30]  A. Fauci,et al.  Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[31]  Mark Groudine,et al.  A block to elongation is largely responsible for decreased transcription of c-myc in differentiated HL60 cells , 1986, Nature.

[32]  B. Peterlin,et al.  Tat competes with CIITA for the binding to P-TEFb and blocks the expression of MHC class II genes in HIV infection. , 2000, Immunity.

[33]  M. Karin,et al.  Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. , 2000, Annual review of immunology.

[34]  B. Peterlin,et al.  Control of RNA initiation and elongation at the HIV-1 promoter. , 1994, Annual review of biochemistry.